. . . . . . . . . . . . . "tscript(p(HGNC:FOXA2)) -> bp(GO:\"fatty acid beta-oxidation\")" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "These abnormalities were cured by adenovirus-mediated expression of a constitutively active form of Foxa2 containing a mutated T156 phosphorylation site, which increases fatty acid oxidation and reduces its biosynthesis. Accordingly, the prevention of phosphorylation of Foxa2 was suggested as a pharmacological target for the treatment of obesity and diabetes." . . "Selventa" . . . . "2014-07-03T14:30:35.943+02:00"^^ . . .